What GLP-1 Weight Loss Programs Actually Cost in 2026
Key Takeaways
- The advertised price is rarely the full cost. Lab work, follow-up visits, shipping, and dose escalation can add $500-$2,000+ per year depending on the program
- Brand-name manufacturer programs (NovoCare, LillyDirect) have dropped prices significantly. Cash-pay is now $199-$449/month depending on the medication and dose.
- With insurance and a savings card, monthly costs can drop to $25. But only about 19-49% of employer plans currently cover GLP-1s for weight management.
- The annual cost gap between different access routes can be over $14,000. How you access the medication matters more than which medication you choose.
GLP-1 medication pricing is confusing by design. A provider advertises "$199/month," but that might be a first-month promotional rate, or it might not include consultations, or it could be the starting dose that goes up as your dose escalates.
The FTC sued telehealth firm NextMed in July 2025 for exactly this kind of practice: advertising $138-$188/month programs without disclosing that medication, labs, and consultations cost extra.
This guide breaks down the cost components that add up beyond the advertised price, and compares what you would actually pay across the most common access routes.
Compare Program Pricing
The Six Components of GLP-1 Program Cost
Most people see one number on a provider's website and think that is the cost. The actual cost has up to six components, and how they are bundled varies by provider.
Cost Components
| Component | Typical Range | How It Adds Up |
|---|---|---|
| Medication | $149-$1,350/mo | The biggest line item. Depends on brand vs compounded, dose, and access route. |
| Provider consultations | $0-$49/visit | $0 when bundled. $348-$588/year when billed monthly at $29-$49 each. |
| Lab work | $0-$129/draw | Baseline plus 2-3 follow-ups = $225-$500/year if paying out of pocket. |
| Shipping | $0-$15/shipment | Usually included. When charged separately: $60-$180/year. |
| Program/membership fees | $0-$145/mo | Some providers charge a separate membership on top of medication cost. |
| App/digital tools | $0-$70/mo | Usually included. Standalone programs (Noom, Calibrate) add $32-$70/mo. |
A program advertising $199/month that includes everything costs $2,388/year. But if another program advertises $149/month and charges separately for consults ($39/mo), labs ($100/quarter), and shipping ($10/mo), the real annual total is $3,276. The cheaper advertised price ends up being $888 more per year.
Brand-Name Manufacturer Programs
Both Novo Nordisk and Eli Lilly have introduced self-pay programs that bring costs well below list price. These programs do not require insurance.
Wegovy® (Semaglutide) through NovoCare
| Option | Monthly Cost | Notes |
|---|---|---|
| Injection (starter doses) | $199/mo | 0.25 mg and 0.5 mg. Introductory pricing through March 31, 2026. |
| Injection (maintenance) | $349/mo | 2.4 mg maintenance dose. |
| Pill (starter) | $149/mo | 1.5 mg and 4 mg. The 4 mg introductory price expires April 15, 2026. |
| Pill (maintenance) | $299/mo | 9 mg and 25 mg doses. |
| With insurance + savings card | As low as $25/mo | Max savings $100/month. Not available for government insurance. |
Zepbound® (Tirzepatide) through LillyDirect
| Option | Monthly Cost | Notes |
|---|---|---|
| Vial (2.5 mg starter) | $299/mo | Single-dose vials, self-pay. |
| Vial (5 mg) | $399/mo | Single-dose vials. |
| Vial (7.5-15 mg maintenance) | $449/mo | Requires refill within 45 days. Self Pay Journey program. |
| With insurance + savings card | As low as $25/mo | Max savings $100/month, $1,300/year cap. |
Pricing sources: NovoCare, Zepbound savings. List prices: Wegovy ~$1,350/mo, Zepbound ~$1,086/mo. Almost nobody pays list price.
Prices are dropping
Novo Nordisk announced a ~50% reduction in Wegovy's wholesale price effective January 1, 2027. LillyDirect lowered vial prices in December 2025. NovoCare launched self-pay programs in November 2025. The trend is toward more affordable brand-name access, but verify current pricing before making decisions.
How Different Program Models Work
Not all telehealth programs structure their pricing the same way. Understanding the model helps you compare total cost, not just the advertised number.
All-Inclusive (One Monthly Fee)
One price covers medication, consultations, shipping, and sometimes labs. What you see advertised is close to what you pay, but "all-inclusive" does not always mean the same thing. Some providers include labs and others do not, so always verify what is actually bundled before signing up.
Typical range: $149-$599/month depending on provider and medication type.
Split Billing (Medication Separate from Services)
The program charges separately for the medical side and the medication side. You might pay $49-$99/month for membership or consultations and then pay for medication through a pharmacy, insurance, or the provider's pharmacy partner. This model can be cheaper if insurance covers the medication, but the separate fees add up when paying out of pocket.
Membership Plus Medication
Some providers charge a membership fee (covering consultations, insurance navigation, provider support) plus medication costs on top. If insurance covers the medication and you just need the copay, this can be the lowest total cost. If paying cash for medication, you are paying two separate monthly fees.
The Question to Ask Every Provider
Before signing up, ask: "What is my total monthly cost at the maintenance dose, including medication, consultations, labs, and shipping?" The answer to that question, not the advertised price, is what you should compare.
Insurance Coverage: The Landscape in 2026
Insurance coverage for GLP-1 weight loss medications is a moving target. The trend is mixed: some employers are expanding coverage even as others scale back.
Employer Coverage Rates
| Employer Size | Covers GLP-1 for Weight Loss |
|---|---|
| 200-999 employees | 16% |
| 1,000-4,999 employees | 30% |
| 5,000+ employees | 43% (up from 28% in 2024) |
Source: KFF 2025 Employer Health Benefits Survey
Only about 1% of ACA marketplace plans cover Wegovy® for weight management, and several major insurers narrowed coverage further starting January 1, 2026, limiting GLP-1s to type 2 diabetes only. The result: 42% more commercially insured people lack Wegovy® coverage compared to 2025.
Medicare currently does not cover anti-obesity medications under Part D. The BALANCE demonstration model, announced December 2025, will begin offering Medicare GLP-1 access around July 2026 with a $50/month patient copay. The TREAT Obesity Act, which would permanently remove the statutory exclusion, has been introduced but not voted on.
If your insurance does cover GLP-1s for weight management, a manufacturer savings card can reduce your copay to as low as $25/month. With that kind of coverage, brand-name medications are significantly cheaper than any cash-pay alternative. The challenge is getting approved: nearly 100% of plans now require prior authorization, up from less than 25% before 2024.
What a Year of Treatment Actually Costs
This table shows the total annual cost across the most common access routes, including medication, consultations, labs, and shipping.
Annual Cost by Access Route (2026)
| Access Route | Annual Total | What's Included |
|---|---|---|
| Insurance + savings card | $300-$900 | Copay only. Consults and labs often covered separately by insurance. |
| NovoCare pill (self-pay) | $1,800-$3,600 | Medication only. Add $225-$500 for labs, provider costs vary. |
| NovoCare injection (self-pay) | $2,400-$4,200 | Medication only. Add labs and provider costs. |
| Telehealth all-inclusive (compounded)* | $2,000-$3,600 | Medication, consults, shipping bundled. Labs may or may not be included. |
| LillyDirect vials (self-pay) | $3,600-$5,400 | Medication only. Add labs and provider costs. |
| Brand-name list price | $13,000-$16,200 | Almost nobody pays this. Included for reference only. |
*Compounded medications are NOT FDA-approved. Compounded GLP-1 availability is subject to regulatory changes. See our compounded GLP-1 guide for current status.
The access route you choose matters more than which medication you take. A year of brand-name semaglutide through NovoCare ($2,400-$4,200 for medication) is in the same range as a year of brand-name tirzepatide through LillyDirect ($3,600-$5,400). With insurance, both drop to roughly the same $300-$900 range.
The biggest cost variable is not the drug. It is how you access it.
The Bottom Line
GLP-1 treatment is a long-term commitment. A January 2026 Oxford/BMJ study found that most people regain weight within 18 months of stopping, which means maintenance pricing of $2,000-$5,400 per year for most self-pay options is not a short-term expense.
Before choosing a provider, get the total monthly cost at the maintenance dose with everything included. Compare that number across options. A program that looks expensive up front but bundles everything may cost less over a year than one with a lower advertised price and separate charges.
Compare What Providers Include
We list what each program covers: medication, consults, labs, shipping. Compare apples to apples.
See Your OptionsHow We Evaluate Program Pricing
We verify pricing for every provider we review by checking their website, terms, and FAQ. We disclose first-month vs ongoing rates, what is included vs what costs extra, and any cancellation policies. When pricing changes, we update our reviews. See our advertiser disclosure for details.
Featured Programs
Compare what each program includes in their pricing.
Sources
- FTC. FTC takes action against NextMed over misleading prices. July 2025.
- NovoCare. Wegovy savings and self-pay programs. Accessed February 2026.
- Eli Lilly. Zepbound savings programs. Accessed February 2026.
- KFF. 2025 Employer Health Benefits Survey. 2025.
- KFF. Employer perspectives on GLP-1 coverage costs. 2025.
- Liu X, et al. Coverage and prior authorization policies for GLP-1s in Medicare Part D. JAMA Network Open. 2025.
- West S, et al. Weight regain following cessation of medication for weight management. BMJ. 2026. DOI: 10.1136/bmj-2025-085304.
- Eli Lilly. Lilly lowers price of Zepbound single-dose vials. December 2025.